-
Mashup Score: 0FDA Approves Brukinsa Tablet For Various Blood Cancers - 12 hour(s) ago
FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as capsules.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 2From Navigating the Unknown to Building a Movement: My DCIS Journey - 15 hour(s) ago
The bad news is you have ductal carcinoma in situ. The good news is that DCIS is the best type of breast cancer to get.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
From Navigating the Unknown to Building a Movement: My DCIS Journey #CancerAdvocacy https://t.co/rtiG8TBOvu
-
-
Mashup Score: 3How Insurance Red Tape Threatens Timely Cancer Care - 17 hour(s) ago
A study explores how prior authorization requirements; coverage stoppages and other red tape can generate barriers to life saving therapies in cancer care.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
How Insurance Red Tape Threatens Timely Cancer Care @CancerCare #CancerCare https://t.co/PSMW9vJML6
-
-
Mashup Score: 13
Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic breast cancer should know.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Understanding the Importance of the DESTINY-Breast09 Trial in HER2+ Breast Cancer @stolaney1 @DanaFarber @DFCI_BreastOnc @ASCO #ASCO35 #bcsm #BreastCancerAwareness https://t.co/CwxrUXBVL8
-
-
Mashup Score: 6Breyanzi Shows Durable Responses in R/R Marginal Zone Lymphoma - 21 hour(s) ago
Breyanzi demonstrated a 95.5% response rate among patients with relapsed/refractory marginal zone lymphoma, as well as a durable safety.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Breyanzi Shows Durable Responses in R/R Marginal Zone Lymphoma @MSKCancerCenter @bmsnews #Lymphoma #MedTwitter #MedEd https://t.co/pF2Q0lAzO9
-
-
Mashup Score: 3FDA Approves Ibtrozi for ROS1+ Advanced Non-Small Cell Lung Cancer - 23 hour(s) ago
The U.S. FDA has approved treatment with Ibtrozi for patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
📢 ICYMI: A New FDA Approval Offers Hope for ROS1+ Lung Cancer The FDA has approved Ibtrozi (taletrectinib) in locally advanced or metastatic ROS1+ NSCLC. 📰 Read the full breakdown, including data, side effects, and what to expect here: https://t.co/cfKQBmenti https://t.co/GkUfZCWdDl
-
-
Mashup Score: 0
Dr. Tiziano Barbui explains how excess blood cell production in certain myeloproliferative neoplasms can impair circulation and why treatments like phlebotomy are used.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Dr. Tiziano Barbui explains how excess blood cell production in certain myeloproliferative neoplasms can impair circulation and why treatments like phlebotomy are used. #MPNs #BloodCancer https://t.co/cyYBJiJgMK
-
-
Mashup Score: 11
Expert oncologists Dr. Joshua K. Sabari and Dr. Eric K. Singhi break down key updates and takeaways in lung cancer treatment following ASCO 2025.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
🚨 Major updates in #LungCancer treatment straight from #ASCO25! Dr. @JSabarind Dr. @lungoncdoc discuss what the latest data mean for you and your loved ones. @ASCO @MDAndersonNews @Perlmutter_CC #ASCO25 🎥 Watch the full video here: https://t.co/ENfhT5JVV0 https://t.co/BAPvC6DEPT
-
-
Mashup Score: 3Cancer Recurrence, Getting Past the Anxiety - 2 day(s) ago
If there is ever an annual follow up CT scan that does not cause me significant anxiety, this year will be the one.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Cancer Recurrence, Getting Past the Anxiety #Oncology https://t.co/rjMJm7pMO1
-
-
Mashup Score: 7Understanding the Whole Person Behind their Cancer Diagnosis - 2 day(s) ago
Dr. Joshua K. Sabari and Jackie Herigodt sat down to discuss the importance of knowing a patient beyond their cancer diagnosis.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Understanding the Whole Person Behind their Cancer Diagnosis @JSabari @JackieHerigodt @Perlmutter_CC @ASCO #ASCO25 https://t.co/gRy5kGmk5l
-
ICYMI: FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as capsules. @US_FDA #Oncology #MedTwitter #BloodCancer Read more here: https://t.co/TFO3kq076K